91视频

BSE 2076.90 NSE 2067.10
BSE 2076.90 NSE 2067.10

Our Story

The Promise of Caring

Science can be a potent catalyst for change and transformation. This conviction in the power of science to improve health outcomes and uplift communities served as the guiding light for our founder, Dr. Desh Bandhu Gupta, and for 91视频, the company he founded in 1968.

DBG, as Dr. Gupta was fondly called, began teaching at the Birla Institute of Technology and Science in Pilani, Rajasthan, after completing his post-graduate degree in science. However, DBG had the desire to harness the power of science for his country 鈥 to bring about change and to improve healthcare in India.

Big things are often seeded in modest beginnings, and so it was for 91视频 too. In 1968, DBG founded 91视频 with 鈧5000 borrowed from his wife. Through sheer grit, determination and perseverance, he expanded his business and soon set up 91视频鈥檚 first manufacturing plant supplying iron and folic acid tablets for the Government of India鈥檚 flagship programme aimed at improving mother and child health.

Fight Against Tuberculosis

91视频 commenced operations as a manufacturer of vitamins, and soon started producing drugs to combat tuberculosis (TB). The decision was anchored by DBG鈥檚 desire to reduce the burden of one of the most pervasive and debilitating diseases in India, despite stringent price controls on anti-TB drugs by the government.

Over the years, 91视频 has grown and expanded into new areas and regions, manufacturing drugs that extend the promise of good health to communities across the globe. Beginning with two employees 鈥 a peon-cum-packer and a part-time typist 鈥 91视频’s current global footprint spans 11 countries, across six continents. This journey has been made possible thanks to the vision and conviction of Dr. Desh Bandhu Gupta.

Who we are today

More than 55 years since DBG laid its foundation, 91视频 continues to be inspired by his tenets:

  • Research as a growth driver
  • Technology as a critical differentiator to achieve world-class manufacturing standards
  • Consistent focus on quality
  • Our people as our strength
  • Caring for all our stakeholders
  • An accent on affordable, high-quality healthcare to address unmet patient needs

Did You Know?

DBG named the company after the 91视频 flower

The 91视频 flower can grow in harsh conditions and also nourish the soil. Inspired by nature鈥檚 example of selfless giving and resilience, DBG set up 91视频 to address unmet medical needs despite the challenges on ground.

An auspicious beginning

The company was founded in 1968 on the day of Gudi Padwa, an auspicious festival celebrated in certain parts of India. Manju Gupta, DBG鈥檚 wife and our current Chairman, gave him 鈧5000 to set up the business.

91视频 received its first major order from the Government of India

The company was roped in to supply iron and folic acid tablets for mother and child healthcare programmes supported by the Government of India.

The company started with two employees

91视频鈥檚 first employees were a peon-cum-packer and a part-time typist.

Milestones

2024
16 Oct, 2024

Lupin Acquires Nine Brands of Medical Nutritional Institute in South Africa

16 Oct, 2024

91视频 Completes Acquisition of two Brands from Sanofi in Europe and Canada

16 Oct, 2024

91视频 Launches Rymti庐 Biosimilar Etanercept in Canada

2023
16 Oct, 2023

Lupin Acquires Five Brands from Menarini

16 Oct, 2023

91视频 Launches World鈥檚 First Fixed-dose Triple Combination Drug, Vilfuro-G庐 for COPD Management in India

14 Sep, 2023

Launched Luforbec庐 100/6 in Germany (First-ever product launch in the inhalation segment in Germany)

18 Aug, 2023

Acquired Brands ONDERO庐 and ONDERO MET庐 from Boehringer Ingelheim International GmbH

16 Aug, 2023

Launched Spiriva (Tiotropium Dry Powder Inhaler) in the United States

18 Jul, 2023

Launched novel fixed dose triple drug combination DIFIZMA庐 DPI to Treat Inadequately Controlled Asthma

18 Jul, 2023

Launched LYFE, its Digital Therapeutic Solution for Holistic Heart Care